Doxycycline enhances survival and self-renewal of human pluripotent stem cells

Stem Cell Reports. 2014 Aug 12;3(2):353-64. doi: 10.1016/j.stemcr.2014.06.013. Epub 2014 Jul 24.

Abstract

We here report that doxycycline, an antibacterial agent, exerts dramatic effects on human embryonic stem and induced pluripotent stem cells (hESC/iPSCs) survival and self-renewal. The survival-promoting effect was also manifest in cultures of neural stem cells (NSCs) derived from hESC/iPSCs. These doxycycline effects are not associated with its antibacterial action, but mediated by direct activation of a PI3K-AKT intracellular signal. These findings indicate doxycycline as a useful supplement for stem cell cultures, facilitating their growth and maintenance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Doxycycline / pharmacology*
  • Embryonic Stem Cells / cytology
  • Humans
  • Karyotyping
  • Neural Stem Cells / cytology
  • Neurons / cytology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / drug effects*
  • Pluripotent Stem Cells / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction / drug effects

Substances

  • Anti-Bacterial Agents
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Doxycycline